Shivalik Rasayan Ltd

Shivalik Rasayan Ltd

₹ 730 -1.42%
06 Jun 3:40 p.m.
About

The company is into manufacturing of agrochemicals and in 2015 it forayed into pharmaceuticals.
The company acquired Medicamen Biotech Limited in 2015 which is engaged in manufacturing pharmaceutical formulations. [1] [2]

Key Points

Business Segments
Shivalik Rasayan is into 2 business segments :

  • Market Cap 1,089 Cr.
  • Current Price 730
  • High / Low 1,107 / 614
  • Stock P/E 72.1
  • Book Value 201
  • Dividend Yield 0.07 %
  • ROCE 5.23 %
  • ROE 5.35 %
  • Face Value 5.00

Pros

  • Company has delivered good profit growth of 24.1% CAGR over last 5 years

Cons

  • Stock is trading at 3.70 times its book value
  • Tax rate seems low
  • Company has a low return on equity of 6.91% over last 3 years.
  • Debtor days have increased from 57.0 to 76.1 days.
  • Working capital days have increased from 110 days to 212 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
14.25 18.23 21.63 22.93 22.08 22.86 24.17 26.89 25.39 24.74 22.80 21.78 24.26
10.67 15.82 18.33 16.52 15.46 16.38 18.39 21.27 20.07 18.57 17.65 17.67 20.63
Operating Profit 3.58 2.41 3.30 6.41 6.62 6.48 5.78 5.62 5.32 6.17 5.15 4.11 3.63
OPM % 25.12% 13.22% 15.26% 27.95% 29.98% 28.35% 23.91% 20.90% 20.95% 24.94% 22.59% 18.87% 14.96%
-0.00 0.13 -0.00 0.23 0.02 -0.00 -0.00 0.47 1.52 0.49 0.33 0.83 0.55
Interest 0.25 0.02 0.18 0.18 0.14 0.31 0.22 0.24 0.32 0.26 0.26 0.39 0.50
Depreciation 0.44 0.95 1.10 2.32 1.69 1.27 1.29 1.35 1.32 1.48 1.22 1.35 1.19
Profit before tax 2.89 1.57 2.02 4.14 4.81 4.90 4.27 4.50 5.20 4.92 4.00 3.20 2.49
Tax % 1.04% -3.18% -3.47% -1.21% -1.04% -1.63% -2.81% -2.00% -4.04% 1.02% -1.00% 9.69% -32.53%
Net Profit 2.86 1.62 2.09 4.19 4.85 4.98 4.38 4.59 5.40 4.87 4.04 2.89 3.31
EPS in Rs 2.08 1.18 1.52 3.04 3.52 3.61 3.18 3.17 3.73 3.36 2.79 1.99 2.28
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
26 29 35 41 43 41 44 48 61 85 99 94
24 27 33 38 38 34 36 42 51 66 76 75
Operating Profit 1 2 2 3 5 7 7 6 9 19 23 19
OPM % 6% 5% 6% 7% 11% 17% 17% 13% 16% 22% 23% 20%
0 0 0 0 1 1 1 4 1 0 2 2
Interest 0 0 0 0 1 2 1 1 1 1 1 1
Depreciation 0 0 0 0 0 0 0 1 1 6 5 5
Profit before tax 1 1 2 3 4 5 6 9 9 13 19 15
Tax % 31% 32% 34% 33% 33% 33% 19% -3% -0% -1% -3% -3%
Net Profit 1 1 1 2 3 3 5 9 9 13 19 15
EPS in Rs 1.01 1.08 1.37 2.10 3.10 3.84 4.84 6.47 6.35 9.20 13.36 10.42
Dividend Payout % -0% -0% -0% -0% -0% 10% 8% 8% 4% 5% 4% -0%
Compounded Sales Growth
10 Years: 12%
5 Years: 16%
3 Years: 15%
TTM: -6%
Compounded Profit Growth
10 Years: 32%
5 Years: 24%
3 Years: 20%
TTM: -22%
Stock Price CAGR
10 Years: %
5 Years: 17%
3 Years: 44%
1 Year: -8%
Return on Equity
10 Years: 8%
5 Years: 7%
3 Years: 7%
Last Year: 5%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
3 3 3 3 3 3 4 7 7 7 7 7
Reserves 4 5 6 8 10 14 42 153 161 173 266 284
2 0 -0 0 11 14 8 9 0 11 15 34
6 8 9 11 12 7 7 10 18 31 29 40
Total Liabilities 15 16 18 23 37 38 61 178 186 223 318 365
6 7 6 7 8 8 15 16 18 120 128 126
CWIP -0 -0 -0 -0 -0 -0 -0 11 61 -0 3 57
Investments -0 -0 -0 -0 16 18 27 27 39 53 55 65
9 10 12 16 13 12 19 124 68 49 131 117
Total Assets 15 16 18 23 37 38 61 178 186 223 318 365

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
6 -3 -1 4 6 4 -2 -12 -7 46 7 -13
-4 0 0 -0 -17 -2 -16 -9 -65 -61 -16 -65
-3 3 0 1 7 -2 19 104 -9 10 76 21
Net Cash Flow -1 -0 -0 4 -4 1 2 83 -81 -5 66 -57

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 78 76 93 80 61 47 64 66 49 70 25 76
Inventory Days 42 32 8 5 14 22 36 82 33 45 97 256
Days Payable 72 112 103 126 139 76 66 92 166 119 108 154
Cash Conversion Cycle 48 -4 -2 -41 -64 -8 34 56 -83 -4 14 179
Working Capital Days 40 4 17 -11 -40 -37 38 169 202 33 86 212
ROCE % 20% 19% 23% 29% 28% 25% 18% 9% 6% 7% 8% 5%

Shareholding Pattern

Numbers in percentages

Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
52.92 52.92 52.92 52.92 52.92 52.92 50.32 50.32 50.32 50.32 50.32 50.32
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.04 0.01 0.01 0.01
47.08 47.08 47.08 47.08 47.08 47.08 49.68 49.62 49.64 49.67 49.67 49.67

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents